Previous 10 | Next 10 |
home / stock / bvaxf / bvaxf news
BioVaxys and The Ohio State University Extend Research Collaboration Canada NewsWire VANCOUVER, BC , Aug. 29, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (5LB: FRA) ("BioVaxys" or "the Company"), is pleased to announce that it has further e...
BIOVAXYS ANNOUNCES MANAGEMENT CHANGE Canada NewsWire VANCOUVER , BC , June 30, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or " Company ") regrets to announce that Dasha Enenko has resigned as CFO of th...
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2023) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) (" BioVaxys " or " Company ") is pleased to announce that it has sold TAET Software Co. to 10402588 BC Ltd ("Purchaser"), a private company formed under the laws of Brit...
BIOVAXYS REPORTS AGM RESULTS Canada NewsWire VANCOUVER, BC , June 7, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or " Company ") is pleased to announce that the results of its Annual General Meeting hel...
(NewsDirect) BioVaxys CEO James Passin joins Natalie Stoberman from the 35th International Papillomavirus Conference in Washington, D.C. to discuss its latest news of retaining New York City-based Maxim Group as its financial advisor and investment banker. Passin says Maxim will handl...
(NewsDirect) BioVaxys CEO James Passin joins Natalie Stoberman from the 35th International Papillomavirus Conference in Washington, D.C. to discuss its latest news of retaining New York City-based Maxim Group as its financial advisor and investment banker. Passin says Maxim will handl...
BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER Canada NewsWire VANCOUVER, British Columbia , April 17, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce tha...
(NewsDirect) BioVaxys CEO James Passin joins Natalie Stoberman from the Proactive newsroom to discuss the company's acquisition of TAETSoftware, a Vancouver-based clinical studies management company engaged in the development and commercialization of the Trial Adverse Events Tracker (TAET) te...
BIOVAXYS ACQUIRES CLINICAL STUDY MANAGEMENT COMPANY AND COMPLETES PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , March 16, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") today announced that it has ...
BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps Canada NewsWire VANCOUVER , British Colombia and BARCELONA, Spain , Dec. 19, 2022 /CNW/ - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ...
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order Canada NewsWire VANCOUVER, BC , May 16, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (the...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Canada NewsWire USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC , May 1, 2024 /CNW/ -- USA News Group ...
BIOVAXYS APPOINTS CHRISTOPHER CHERRY AS CHIEF FINANCIAL OFFICER Canada NewsWire VANCOUVER, BC , April 30, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") is pleased to announce that it has appointed Chris...